Katherine E. Varley, Ph.D.
Affiliations: | 2009 | Washington University, Saint Louis, St. Louis, MO |
Area:
Molecular Biology, Biochemistry, GeneralGoogle:
"Katherine Varley"Parents
Sign in to add mentor| Robi D. Mitra | grad student | 2009 | Washington University | |
| (Methods to identify genetic and epigenetic mutations in cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Wallace AD, Sasani TA, Swanier J, et al. (2021) CaBagE: A Cas9-based Background Elimination strategy for targeted, long-read DNA sequencing. Plos One. 16: e0241253 |
| Conway ME, McDaniel JM, Graham JM, et al. (2020) STAT3 and GR cooperate to drive gene expression and growth of basal-like triple-negative breast cancer. Cancer Research |
| Stewart RL, Matynia AP, Factor RE, et al. (2020) Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis. Scientific Reports. 10: 6598 |
| Martín M, Updike KL, Rodríguez-Lescure A, et al. (2020) Abstract P1-10-09: The MHCII immune activation assay is prognostic for disease free survival in basal-like TNBC breast cancer patients in the GEICAM/9906 clinical trial Cancer Research |
| Stewart RL, Updike KL, Factor RE, et al. (2019) A multigene assay determines risk of recurrence in patients with triple-negative breast cancer. Cancer Research |
| Giraddi RR, Chung CY, Heinz RE, et al. (2018) Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development. Cell Reports. 24: 1653-1666.e7 |
| Guillen KP, Scherer SD, Qiao Y, et al. (2018) Abstract LB-038: Predicting breast cancer therapy response using a patient-derived xenograft organoid screening platform Cancer Research. 78 |
| Yang C, Gaffney DK, Werner TL, et al. (2017) Abstract 1756: Genomic reclassification of endometrial carcinoma predicts drug response and facilitates refinement of current management based on PDX-guided efficacy outcomes Cancer Research. 77: 1756-1756 |
| McDaniel JM, Varley KE, Gertz J, et al. (2016) Genomic regulation of invasion by STAT3 in triple negative breast cancer. Oncotarget |
| Forero A, Li Y, Chen D, et al. (2016) Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells is Associated with a Good Prognosis and Infiltrating Lymphocytes. Cancer Immunology Research |